Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing
Year: 2026
Type: article
Authors: Meilin Zhu, Andile Mtshali, Gugulethu Mzobe, Nzuzo Magini, Nireshni Mitchev, Anam Khan, Briah Cooley Demidkina, Meena Murthy, Lara Lewis, Jiawu Xu, Johnathan Shih, Joseph Elsherbini, Asavela Kama, Nomfuneko A Mafunda, Callin Chetty, Laura Vermeren, Jo-Ann S Passmore, Anna-Ursula Happel, Douglas S Kwon, Laura Symul, Disebo Potloane, Sinaye Ngcapu, Caroline M Mitchell
Institutions: Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Massachusetts General Hospital, UCLouvain, University of Cape Town, Stellenbosch University, Institute of Infectious Disease and Molecular Medicine, Harvard University
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Awards: CAPRISA - to conduct a First in Human clinical trial of a live biotherapeutic intervention for vaginal dysbiosis and reduction of bacterial vaginosis, The General Hospital Corporation d/b/a Massachusetts General Hospital - to create a platform for adaptive clinical trials of interventions for vaginal dysbiosis and plan future studies., The General Hospital Corporation d/b/a Massachusetts General Hospital - to conduct a First in Human clinical trial of a live biotherapeutic intervention for vaginal dysbiosis and reduction of bacterial vaginosis
OpenAlex ID: W7202193285